Cytodyn Inc (CYDY)

[Bill_ENG]

NP stated that the mortality on the OLE patients was 17%, which was better than the results of the CD12 trial. That was counting 55 OLE patients at 28 days.

Because those 55 were at 28 days and were not the total number of OLE patients, the number will keep increasing of patients treated. This will continue until CD16 and CD17 begin, if that ever happens.

I think at tis time we have approx 90 EINDs, 390 from CD12, 55 PLus on the OLE, 29 Philippine CSP so over 563 patients treated with LL for Covid19.

With the CSPs cranking up in the Philippines this number will grow quickly.

I think the "Manila 28" were treated under 1 CSP for the Hospital, this can be used more effectively than the EINDs at US Hospitals that require lots of paperwork per patient and are individual EINDs.